Makers Laboratories (BOM:506919) Cyclically Adjusted PB Ratio: (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506919 Makers Laboratories Ltd BOM:506919
69 GF Score
Price ₹189.45
GF Value ₹182.79
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Makers Laboratories Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Makers Laboratories  (BOM:506919) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Makers Laboratories Cyclically Adjusted PB Ratio Related Terms


Makers Laboratories Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Makers Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Makers Laboratories Cyclically Adjusted PB Ratio Chart

Makers Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.09 1.02 1.08 1.16 1.14

Makers Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.12 0.00 1.14 0.00

BOM:506919 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Makers Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Makers Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Makers Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Makers Laboratories's Cyclically Adjusted PB Ratio falls into.


BOM:506919
69GF Score
Makers Laboratories Ltd BOM:506919
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Makers Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Makers Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Makers Laboratories's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Makers Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201609 55.935 105.961 88.345
201612 0.000 105.196 0.000
201703 66.466 105.196 105.741
201706 0.000 107.109 0.000
201709 65.753 109.021 100.937
201712 0.000 109.404 0.000
201803 71.848 109.786 109.524
201806 0.000 111.317 0.000
201809 74.995 115.142 109.004
201812 0.000 115.142 0.000
201903 81.369 118.202 115.207
201906 0.000 120.880 0.000
201909 77.976 123.175 105.946
201912 0.000 126.235 0.000
202003 87.062 124.705 116.839
202006 0.000 127.000 0.000
202009 101.072 130.118 129.999
202012 0.000 130.889 0.000
202103 105.617 131.771 134.141
202106 0.000 134.084 0.000
202109 113.686 135.847 140.056
202112 0.000 138.161 0.000
202203 121.172 138.822 146.079
202206 0.000 142.347 0.000
202209 121.523 144.661 140.589
202212 0.000 145.763 0.000
202303 117.290 146.865 133.656
202306 0.000 150.280 0.000
202309 111.428 151.492 123.098
202312 0.000 152.924 0.000
202403 106.858 153.035 116.859
202406 0.000 155.789 0.000
202409 120.174 157.882 127.386
202412 0.000 158.323 0.000
202503 119.502 157.552 126.939
202506 0.000 159.755 0.000
202509 119.938 162.289 123.684
202512 0.000 163.281 0.000
202603 123.600 164.272 125.921
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Makers Laboratories (BOM:506919) Overvalued in 2026?

Based on GuruFocus' analysis, Makers Laboratories stock appears to be overvalued. The current stock price of ₹189.45 is trading 3.6% above its estimated GF Value™ of ₹182.79. GuruFocus considers Makers Laboratories to be Fairly Valued.

Key valuation signals for BOM:506919:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹182.79 vs. price of ₹189.45 (3.6% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the BOM:506919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Makers Laboratories Business Description

Other Exchanges MAKERSL:India
Address 54-D, Kandivli Industrial Estate, Charkop, Kandivali (West), Mumbai, MH, IND, 400067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough Range), and Exylin (Amoxycillin range), among others. The reportable segment of the company is the Pharmaceutical segment.
69GF Score

Get the complete analysis for BOM:506919

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹189.45
Price
₹182.79
GF Value